Tag Archives: OptilumeTM BPH

Laborie to Acquire Urotronic, Expanding Its Medical Technology Portfolio

(IN BRIEF) Laborie, a subsidiary of Patricia Industries, is set to acquire the remaining 91 percent of Urotronic, a US medical technology company known for its OptilumeTM device for treating benign prostatic hyperplasia (BPH). In 2020, Laborie entered a strategic … Read the full press release